These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 21685422

  • 1. Anthelmintic resistance: potential benefits of 'over-diagnosis'.
    Sargison ND, Scott PR.
    Vet Rec; 2011 Jun 18; 168(24):646-7. PubMed ID: 21685422
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Lack of reversion in triclabendazole-resistant Fasciola hepatica.
    Borgsteede FH, Moll L, Vellema P, Gaasenbeek CP.
    Vet Rec; 2005 Mar 12; 156(11):350-1. PubMed ID: 15789649
    [No Abstract] [Full Text] [Related]

  • 6. Activity of closantel against adult triclabendazole-resistant Fasciola hepatica.
    Coles GC, Rhodes AC, Stafford KA.
    Vet Rec; 2000 Apr 22; 146(17):504. PubMed ID: 10888001
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Resistance of Fasciola hepatica to triclabendazole and albendazole in sheep in Spain.
    Alvarez-Sánchez MA, Mainar-Jaime RC, Pérez-García J, Rojo-Vázquez FA.
    Vet Rec; 2006 Sep 23; 159(13):424-5. PubMed ID: 16998003
    [No Abstract] [Full Text] [Related]

  • 10. Increase of carboxylesterase activity in Fasciola hepatica recovered from triclabendazole treated sheep.
    Scarcella S, Miranda-Miranda E, Cossío-Bayúgar R, Ceballos L, Fernandez V, Solana H.
    Mol Biochem Parasitol; 2012 Oct 23; 185(2):151-3. PubMed ID: 22814337
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Diagnosis of resistance to triclabendazole.
    Jones EM, Daniel R, Coles GC.
    Vet Rec; 2014 May 31; 174(22):560. PubMed ID: 24920715
    [No Abstract] [Full Text] [Related]

  • 13. Resistance of Fasciola hepatica against Triclabendazole in cattle in Cajamarca (Peru): a clinical trial and an in vivo efficacy test in sheep.
    Ortiz P, Scarcella S, Cerna C, Rosales C, Cabrera M, Guzmán M, Lamenza P, Solana H.
    Vet Parasitol; 2013 Jul 01; 195(1-2):118-21. PubMed ID: 23352107
    [Abstract] [Full Text] [Related]

  • 14. A study of a restricted programme of strategic dosing against Fasciola hepatica with triclabendazole.
    Fawcett AR.
    Vet Rec; 1990 Nov 17; 127(20):492-3. PubMed ID: 2275087
    [Abstract] [Full Text] [Related]

  • 15. [Fasciolinip-1: experimental fasciolicidal activity in sheep].
    Ibarra-Velarde F, Vera-Montenegro Y, Olazarán-Jenkins S, Hernández-Campos A, Castillo-Bocanegra R.
    Rev Latinoam Microbiol; 1995 Nov 17; 37(2):171-8. PubMed ID: 8552877
    [Abstract] [Full Text] [Related]

  • 16. Extension of the prepatent period of Fasciola hepatica in infected animals following treatment with triclabendazole.
    Büscher G, Bowen FL, Strong MB, Allison JR, Richards RJ.
    Vet Rec; 1987 May 09; 120(19):460-1. PubMed ID: 3603988
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Fasciola hepatica: histological changes in the reproductive structures of triclabendazole (TCBZ)-sensitive and TCBZ-resistant flukes after treatment in vivo with TCBZ and the related benzimidazole derivative, Compound Alpha.
    Hanna RE, Edgar HW, McConnell S, Toner E, McConville M, Brennan GP, Devine C, Flanagan A, Halferty L, Meaney M, Shaw L, Moffett D, McCoy M, Fairweather I.
    Vet Parasitol; 2010 Mar 25; 168(3-4):240-54. PubMed ID: 20053501
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.